• September 21, 2026
  • Last Update September 21, 2026 9:27 pm

durvalumab

  • July 21, 2026

Costa Rica Approves Groundbreaking AstraZeneca Immunotherapy for Bladder Cancer Patients

San José, Costa Rica — Costa Rica’s medical regulatory landscape has marked a significant milestone with the approval of AstraZeneca’s…